City of Hope has so many breakthroughs in cancer, diabetes and HIV/AIDS - and so many stories - that we've tailored our blog, Breakthroughs, to provide something for every reader. Whether the breakthroughs are about medical research, treatment advances or personal triumphs, they're all connected.
April 4, 2017 | Stephanie Smith
City of Hope is dedicating every day in April, National Minority Health Month, to beginning to examine important issues of disparity in health care.
February 7, 2017 | Jyoti Madhusoodanan
Next-generation sequencing (NGS) tests can quickly pinpoint tumor mutations that can be targeted with specific drugs, offering a route to precision therapies for many cancer types. Coupled with new drugs that target tumor-specific genomic changes, NGS tests carry the potential to transform modern cancer care.
June 22, 2016 | Michael Easterling
Victoria Seewaldt, M.D., the Ruth Ziegler professor and chair in the Department of Population Sciences at City of Hope, has received a two-year grant from the Prevent Cancer Foundation to support her research in early detection and triple-negative breast cancer, a highly aggressive form of cancer.
May 28, 2015 | Nicole Levine
A clinical trial currently being conducted at City of Hope and elsewhere suggests that researchers are developing improved treatment options for young women with advanced triple-negative breast cancer, a particularly difficult-to-treat disease.
January 22, 2015 | Nicole White
No one ever plans to have cancer – and there’s never a good time. For Homa Sadat, her cancer came at a particularly bad time: just one year after losing her father to the pancreatic cancer he had battled for two years.
January 15, 2015 | Nicole White
When Homa Sadat found a lump in her breast at age 27, her gynecologist told her what many doctors say to young women: You’re too young to have breast cancer. Triple-negative breast cancer is diagnosed at a higher rate in patients with BRCA-related breast cancer and in African-American women.
December 24, 2014 | Tami Dennis
Yuman Fong, M.D., is an internationally recognized expert in hepatobiliary cancer – that is liver cancer, pancreatic cancer, gallbladder cancer and cancer of the bile ducts. He's also renowned for his use of genetically modified viruses to combat malignant disease, is a pioneer in the operating room and the laboratory, is the author of more than 600 peer-reviewed articles and 11 textbooks, and is the chair of the Department of Surgery at City of Hope.
September 24, 2014 | Nicole White
Runners prize medals for 5Ks and marathons. Becky Stokes has a medal she cherishes from a very different kind of race: the marathon of treatments necessary to beat her aggressive triple-negative breast cancer.
July 15, 2014 | Nicole White
At 29, Kommah McDowell was a successful young professional engaged to be married to her best friend. She worked in the financial services sector and kick-boxed to keep in shape and to relax. Then came the diagnosis of triple-negative inflammatory breast cancer, a rare and very aggressive form of breast cancer.
May 3, 2013 | Nicole White
A City of Hope researcher has been awarded a grant to use neural stem cells, which naturally home in on cancer cells (shown here), to deliver cancer-fighting drugs. Triple-negative breast cancer is both aggressive and tough to fight with existing therapies, a combination that often results in the disease's spread; in fact, most deaths related to this form of cancer occur due to metastases.
Load MoreBack To Top